Mayr-Melnhof with significant declines in sales and earnings after nine months
Intensive competition with high price pressure and significantly increased prices are weighing on the Board & Paper division - revenue growth thanks to GLP-1 medication uptake
We haven't written up this one. Der Standard Wirtschaft has the full story — the link below goes straight to it.
Also reported by 1 other outlet
- Lenzing with less sales and more loss after nine months derstandard.at